Cambridge

Horizontal Tabs

Treatment Modalities 
Cytotoxic therapeutics
Immunotherapy
Molecular Targeted Therapies
Radiotherapy
Facilities/Translational Research 
Phase 1 Capability
  • Phase I population: solid tumours and haematology, adult and paediatric
  • First-in-human studies
  • Combination phase I trials
  • Centre specific translational research interest: sequential biopsies (window studies), molecular imaging, clinical genomics
  • Multi-centre phase I studies
Technology/equipment available within the centre
  • 3T MRI facility
  • Genomics and bioinformatics
  • Molecular pathology
  • Equipment for isolation of circulating tumour cells
Other Facilities
  • Wellcome Trust Clinical Research Facility (CRF)
  • Cambridge Breast Cancer Research Unit
  • Cambridge Cancer Trials Centre
  • Cambridge Clinical Trials Unit
  • MRC Biostatistics Unit